Rex Kung

UPenn MSTP ‘33

[Mark Yarchoan @MarkYarchoan]

1/ Excited to share our newest study in Nat Med on a vaccine targeting the recurrent fusion DNAJ-PKAc in #fibrolamellar carcinoma (FLC), a rare liver cancer affecting kids & young adults

Full paper: https://t.co/ZjKtNEcAup

@PGTimmune & @marinabaretti & @FibroFoundation

[Joseph Fraietta @JoeFraietta]

Happy to announce publication of our new paper: CCR5-targeted allogeneic gamma–delta CD19 chimeric antigen receptor T cells for HIV-associated B cell-malignancy immunotherapy | Nature Biomedical Engineering Congratulations, Angel and Team!!! https://t.co/zm3HWHTvcz

[Anirban Maitra @Aiims1742]

Nice review here in @NatRevClinOncol
The tumour microenvironment in #PancreaticCancer — new clinical challenges, but more opportunities
https://t.co/xClZIjZHfe
By Lei Zheng @mayscancer @KimmelCancerCtr

[Rex Kung @RexKung0525]

@darrell_fan_ @laleh_melstrom Inspirational! Congratulations!

[Rex Kung @RexKung0525]

Couldn’t have asked for a better mentor in Bart! https://t.co/AV7gSDEjpR

[Denis Wirtz @deniswirtz]

Four great members of the Wirtz/Wu group are graduating with a PhD this year.

Dr. Adrian Johnston (tumor-infiltrating CAR TV cells )
Dr. Ashleigh Crawford (multi-compartment organoids)
Dr. Kyu Sang Han (CODA of the human skin)
Dr. Bart Starich (senescence, stiffness-induced EVs)